成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
400-158-6606
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook >> CAS DataBase List >> Nintedanib esylate

Nintedanib esylate

Nintedanib esylate price.
  • $7 - $2233.8
  • Product name: Nintedanib esylate
  • CAS: 656247-18-6
  • MF: C33H39N5O7S
  • MW: 649.76
  • EINECS:
  • MDL Number:MFCD26142360
  • Synonyms:(3Z)-2,3-Dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid methyl ester ethanesulfonate ;BIBF 1120 esylate;BIBF-1120 esylate;BIBF1120/nintedanib ethanesulfonate salt;Trinidad Neeb esylate;Intedanib ethanesulfonate;Nintedanib ethanesulfonate salt;Trinidad Neeb ethanesulfonate
35 prices
Selected condition:
Brand
  • AK Scientific
  • Ambeed
  • American Custom Chemicals Corporation
  • Biorbyt Ltd
  • Biosynth Carbosynth
  • Chemenu
  • ChemScene
  • Crysdot
  • DC Chemicals
  • Labseeker
  • Matrix Scientific
  • TRC
Package
  • 5MG
  • 10mg
  • 25mg
  • 50mg
  • 100mg
  • 200mg
  • 250mg
  • 500mg
  • 1g
  • 2g
  • 5g
  • 10g
  • ManufacturerAK Scientific
  • Product number9942AL
  • Product descriptionNintedanibesylate
  • Packaging25mg
  • Price$67.2
  • Updated2021-12-16
  • Buy
  • ManufacturerAK Scientific
  • Product numberJ51091
  • Product descriptionNintedanibesylate
  • Packaging1g
  • Price$178
  • Updated2021-12-16
  • Buy
  • ManufacturerAmbeed
  • Product numberA160216
  • Product description(Z)-Methyl3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylateethanesulfonate 98+%
  • Packaging100mg
  • Price$7
  • Updated2021-12-16
  • Buy
  • ManufacturerAmbeed
  • Product numberA160216
  • Product description(Z)-Methyl3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylateethanesulfonate 98+%
  • Packaging250mg
  • Price$14
  • Updated2021-12-16
  • Buy
  • ManufacturerAmbeed
  • Product numberA160216
  • Product description(Z)-Methyl3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylateethanesulfonate 98+%
  • Packaging5g
  • Price$136
  • Updated2021-12-16
  • Buy
  • ManufacturerAmerican Custom Chemicals Corporation
  • Product numberCHM0292797
  • Product description(3Z)-2,3-DIHYDRO-3-[[[4-[METHYL[2-(4-METHYL-1-PIPERAZINYL)ACETYL]AMINO]PHENYL]AMINO]PHENYLMETHYLENE]-2-OXO-1H-INDOLE-6-CARBOXYLIC ACID METHYL ESTER ETHANESULFONATE 95.00%
  • Packaging5MG
  • Price$497.93
  • Updated2021-12-16
  • Buy
  • ManufacturerBiorbyt Ltd
  • Product numberorb180030
  • Product descriptionNintedanib, Ethanesulfonate Salt >99%
  • Packaging25mg
  • Price$304.3
  • Updated2021-12-16
  • Buy
  • ManufacturerBiorbyt Ltd
  • Product numberorb180030
  • Product descriptionNintedanib, Ethanesulfonate Salt >99%
  • Packaging50mg
  • Price$357
  • Updated2021-12-16
  • Buy
  • ManufacturerBiorbyt Ltd
  • Product numberorb180030
  • Product descriptionNintedanib, Ethanesulfonate Salt >99%
  • Packaging100mg
  • Price$414.8
  • Updated2021-12-16
  • Buy
  • ManufacturerBiorbyt Ltd
  • Product numberorb180030
  • Product descriptionNintedanib, Ethanesulfonate Salt >99%
  • Packaging200mg
  • Price$433.5
  • Updated2021-12-16
  • Buy
  • ManufacturerBiorbyt Ltd
  • Product numberorb180030
  • Product descriptionNintedanib, Ethanesulfonate Salt >99%
  • Packaging500mg
  • Price$671.5
  • Updated2021-12-16
  • Buy
  • ManufacturerBiorbyt Ltd
  • Product numberorb180030
  • Product descriptionNintedanib, Ethanesulfonate Salt >99%
  • Packaging1g
  • Price$705.5
  • Updated2021-12-16
  • Buy
  • ManufacturerBiorbyt Ltd
  • Product numberorb180030
  • Product descriptionNintedanib, Ethanesulfonate Salt >99%
  • Packaging2g
  • Price$1174.7
  • Updated2021-12-16
  • Buy
  • ManufacturerBiorbyt Ltd
  • Product numberorb180030
  • Product descriptionNintedanib, Ethanesulfonate Salt >99%
  • Packaging5G
  • Price$2233.8
  • Updated2021-12-16
  • Buy
  • ManufacturerBiosynth Carbosynth
  • Product numberFD71497
  • Product descriptionNintedanib ethanesulfonate
  • Packaging25mg
  • Price$60
  • Updated2021-12-16
  • Buy
  • ManufacturerBiosynth Carbosynth
  • Product numberFD71497
  • Product descriptionNintedanib ethanesulfonate
  • Packaging50mg
  • Price$100
  • Updated2021-12-16
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
AK Scientific 9942AL Nintedanibesylate 25mg $67.2 2021-12-16 Buy
AK Scientific J51091 Nintedanibesylate 1g $178 2021-12-16 Buy
Ambeed A160216 (Z)-Methyl3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylateethanesulfonate 98+% 100mg $7 2021-12-16 Buy
Ambeed A160216 (Z)-Methyl3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylateethanesulfonate 98+% 250mg $14 2021-12-16 Buy
Ambeed A160216 (Z)-Methyl3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylateethanesulfonate 98+% 5g $136 2021-12-16 Buy
American Custom Chemicals Corporation CHM0292797 (3Z)-2,3-DIHYDRO-3-[[[4-[METHYL[2-(4-METHYL-1-PIPERAZINYL)ACETYL]AMINO]PHENYL]AMINO]PHENYLMETHYLENE]-2-OXO-1H-INDOLE-6-CARBOXYLIC ACID METHYL ESTER ETHANESULFONATE 95.00% 5MG $497.93 2021-12-16 Buy
Biorbyt Ltd orb180030 Nintedanib, Ethanesulfonate Salt >99% 25mg $304.3 2021-12-16 Buy
Biorbyt Ltd orb180030 Nintedanib, Ethanesulfonate Salt >99% 50mg $357 2021-12-16 Buy
Biorbyt Ltd orb180030 Nintedanib, Ethanesulfonate Salt >99% 100mg $414.8 2021-12-16 Buy
Biorbyt Ltd orb180030 Nintedanib, Ethanesulfonate Salt >99% 200mg $433.5 2021-12-16 Buy
Biorbyt Ltd orb180030 Nintedanib, Ethanesulfonate Salt >99% 500mg $671.5 2021-12-16 Buy
Biorbyt Ltd orb180030 Nintedanib, Ethanesulfonate Salt >99% 1g $705.5 2021-12-16 Buy
Biorbyt Ltd orb180030 Nintedanib, Ethanesulfonate Salt >99% 2g $1174.7 2021-12-16 Buy
Biorbyt Ltd orb180030 Nintedanib, Ethanesulfonate Salt >99% 5G $2233.8 2021-12-16 Buy
Biosynth Carbosynth FD71497 Nintedanib ethanesulfonate 25mg $60 2021-12-16 Buy
Biosynth Carbosynth FD71497 Nintedanib ethanesulfonate 50mg $100 2021-12-16 Buy

Properties

Melting point :>233°C (dec.)
storage temp. :-20°C Freezer
solubility :DMSO (Slightly), Methanol (Slightly)
form :Yellow solid.
color :Light Yellow to Yellow
InChIKey :MMMVNAGRWOJNMW-FJBFXRHMSA-N
SMILES :S(O)(=O)(=O)CC.C(/C1C=CC=CC=1)(=C1\C(NC2=CC(C(=O)OC)=CC=C\12)=O)\NC1C=CC(N(C)C(=O)CN2CCN(C)CC2)=CC=1

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H302 Harmful if swallowed Acute toxicity,oral Category 4 Warning GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 Causes skin irritation Skin corrosion/irritation Category 2 Warning GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 Causes serious eye irritation Serious eye damage/eye irritation Category 2A Warning GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 May cause respiratory irritation Specific target organ toxicity, single exposure;Respiratory tract irritation Category 3 Warning GHS hazard pictograms
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

Description

Nintedanib esylate is a potent, oral triple angiokinase inhibitor developed by Boehringer Ingelheim that targets proangiogenic and pro-fibrotic pathways mediated by the vascular endothelial growth factor receptor, fibroblast growth factor receptor and plateletderived growth factor receptor families, as well as Src and Flt-3 kinases. It was approved for the treatment of idiopathic pulmonary fibrosis (IPF), a condition in which the lungs become progressively scarred over time, by the US FDA in October 2014 and by the EMA in January 2015. The FDA granted nintedanib esylate fast-track, priority review, orphan product, and breakthrough designations. The drug was also approved by the EMA in November 2014 for treatment of non-small cell lung cancer in combination with docetaxel after first-line chemotherapy.